Tissue Distribution: DPP-4 is present in many organs and tissues of the human body (the intestinal and renal epithelium, blood vessel walls, pancreas, liver, gland cells, gut, as well as lymphocytes) [5]
Repeated injections of DSIP in a 35-year-old male narcoleptic investigated the effects of the neuropeptide on these very symptoms and concluded that DSIP reduced the frequency of daytime sleep attacks and increased the individual's daytime performance in terms of overall alertness and activity
Barton, Ph.D., of the Mayo Clinic in Rochester, Minn., who was invited to discuss the research
30,31,37 Notwithstanding, practitioners should continue to be vigilant for the worsening of suicidality for any persons prescribed and self-administering GLP-1 RAs